Indication
Secretin stimulation testing
Secretin stimulation testing is a diagnostic procedure rather than a distinct disease entity. Read more about Secretin stimulation testing
1 drugs 1 manufacturers
Drugs that treat it
Common Secretin stimulation testing therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSecretin stimulation testing is a diagnostic procedure rather than a distinct disease entity.
It is utilized primarily in gastrointestinal and endocrine medicine to evaluate suspected exocrine pancreatic insufficiency, chronic pancreatitis, and neuroendocrine tumors such as gastrinomas associated with Zollinger-Ellison syndrome.
The evaluation involves administering exogenous secretin to provoke specific biochemical responses: measuring peak pancreatic bicarbonate output via duodenal aspiration to assess ductal and acinar secretory capacity, or tracking paradoxical elevations in serum gastrin levels, which distinguish gastrinoma tissue from normal gastric antral G-cell regulation.
- cancer.gov
Secretin stimulation testing is a diagnostic procedure rather than a distinct disease entity It is utilized primarily in gastrointestinal and endocrine medicine to evaluate suspected exocrine pancreatic insufficiency, chronic pancreatitis, and neuroendocrine tumors such as gastrinomas associated with Zollinger-Ellison syndrome The evaluation involves administering exogenous secretin to provoke specific biochemical responses: measuring peak pancreatic bicarbonate output via duodenal aspiration to...
- nih.gov
Secretin stimulation testing is a diagnostic procedure rather than a distinct disease entity
- fda.gov
It is utilized primarily in gastrointestinal and endocrine medicine to evaluate suspected exocrine pancreatic insufficiency, chronic pancreatitis, and neuroendocrine tumors such as gastrinomas associated with Zollinger-Ellison syndrome The evaluation involves administering exogenous secretin to provoke specific biochemical responses: measuring peak pancreatic bicarbonate output via duodenal aspiration to assess ductal and acinar secretory capacity, or tracking paradoxical elevations in serum gas...
- nih.gov
It is utilized primarily in gastrointestinal and endocrine medicine to evaluate suspected exocrine pancreatic insufficiency, chronic pancreatitis, and neuroendocrine tumors such as gastrinomas associated with Zollinger-Ellison syndrome
- labcorp.com
The evaluation involves administering exogenous secretin to provoke specific biochemical responses: measuring peak pancreatic bicarbonate output via duodenal aspiration to assess ductal and acinar secretory capacity, or tracking paradoxical elevations in serum gastrin levels, which distinguish gastrinoma tissue from normal gastric antral G-cell regulation
Personalize your experience
Follow Secretin stimulation testing and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.